SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-006901
Filing Date
2024-02-15
Accepted
2024-02-15 17:27:49
Documents
14
Period of Report
2024-02-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35031
  Complete submission text file 0001493152-24-006901.txt   207564

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lctx-20240214.xsd EX-101.SCH 3024
3 XBRL LABEL FILE lctx-20240214_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lctx-20240214_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3645
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12830 | Film No.: 24644953
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)